HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors.

AbstractINTRODUCTION:
Alveolar haemorrhage (AH) is considered an important cause of morbidity and early mortality in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV).
OBJECTIVES:
The aim of this study was to identify predictors of outcome in patients with AH-AAV and to evaluate outcome and causes of death in this subset.
MATERIALS AND METHODS:
A multicenter retrospective study was conducted in 29 Italian Centers. Clinicians were asked to recruit all patients diagnosed with AAV-associated AH during the last 10 years, from 2007 to 2016. Univariate and multivariable analysis were performed.
RESULTS:
One-hundred and six patients were included (median age at onset of 55 years [IQR 42-67]). The majority were ANCA-positive (PR3 57.1%, MPO 33.7%) and 72.6% had also renal involvement. At presentation, anaemia was shown in 97 (92.4%) patients, hemoptysis in 54 (51.9%), respiratory failure in 68 (66.7%), of whom 48 (70.6%), requiring respiratory support. At the end of the 37 months [IQR 13-77] follow-up, 19/106 (17.9%) patients were dead. The main causes of death were active disease and infections. By stepwise regression analysis, age >65 years (HR 3.66 [95% CI 1.4-9.51], p = 0.008) and the need for respiratory support (HR 4.58 [95% CI 1.51-13.87], p = 0.007) at AH onset were confirmed to be predictive of mortality.
CONCLUSIONS:
Predictors of outcome in AAV-AH were determined. Factors related to the patient's performance status and the severity of the lung involvement strongly influenced the outcome. Balancing harms and benefits for the individual patient in induction and maintenance treatment strategies is crucial.
AuthorsLuca Quartuccio, Milena Bond, Miriam Isola, Sara Monti, Mara Felicetti, Federica Furini, Stefano Murgia, Alvise Berti, Elena Silvestri, Giulia Pazzola, Enrica Bozzolo, Pietro Leccese, Bernd Raffeiner, Simone Parisi, Ilaria Leccese, Francesco Cianci, Silvano Bettio, Pierpaolo Sainaghi, Aurora Ianniello, Viviana Ravagnani, Silvia Bellando Randone, Paola Faggioli, Claudia Lomater, Paolo Stobbione, Francesco Ferro, Michele Colaci, Giuseppina Alfieri, Francesco Carubbi, Gian Luca Erre, Alessandro Giollo, Nicoletta Franzolini, Maria Chiara Ditto, Silvia Balduzzi, Roberto Padoan, Roberto Bortolotti, Alessandra Bortoluzzi, Adriana Cariddi, Angela Padula, Gerardo Di Scala, Elisa Gremese, Fabrizio Conti, Salvatore D'Angelo, Marco Matucci Cerinic, Lorenzo Dagna, Giacomo Emmi, Carlo Salvarani, Giuseppe Paolazzi, Dario Roccatello, Marcello Govoni, Franco Schiavon, Roberto Caporali, Salvatore De Vita, Italian Study Group on Lung Involvement in Rheumatic Diseases and the Italian Vasculitis Study Group
JournalJournal of autoimmunity (J Autoimmun) Vol. 108 Pg. 102397 (03 2020) ISSN: 1095-9157 [Electronic] England
PMID31926833 (Publication Type: Journal Article, Multicenter Study)
CopyrightCopyright © 2020 Elsevier Ltd. All rights reserved.
Topics
  • Adult
  • Aged
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (complications, diagnosis, epidemiology, mortality)
  • Female
  • Hemorrhage (diagnosis, epidemiology, etiology, mortality)
  • Humans
  • Italy (epidemiology)
  • Male
  • Middle Aged
  • Mortality
  • Prognosis
  • Public Health Surveillance
  • Pulmonary Alveoli (pathology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: